Vol 49, No 6 (2015)

open access

Page views 321
Article views/downloads 395
Get Citation

Connect on Social Media

Connect on Social Media

A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer – Case report and literature review

Magda Dąbrowska1, Tomasz Drabarek1, Anna Muraszko-Klaudel2, Jarosław Sławek13
DOI: 10.1016/j.pjnns.2015.09.005
Neurol Neurochir Pol 2015;49(6):460-466.


We report a rare case of tuberculosis of the thoracic spine caused by Mycobacterium bovis infection as a complication of BCG (Bacillus Calmette-Guérin) intravesical immunotherapy, which is a well known and acknowledged treatment of superficial bladder cancers applied since 1976. Although this therapy is broadly used in urology and considered to be safe and well tolerated, one should be aware of the potential local and systemic side effects as in the case of our patient, who developed tuberculous spondylodiscitis after intravesical BCG therapy.

Article available in PDF format

View PDF Download PDF file

Neurologia i Neurochirurgia Polska